Omeros CorpNASDAQ:OMER
- LAST PRICE3.9700
- TODAY'S CHANGE (%)-0.0900 (-2.2167%)
- Bid / Lots3.9500/ 9
- Ask / Lots3.9700/ 4
- Open / Previous Close4.0500 / 4.0600
- Day Range
- 52 Week Range
- Volume130,927
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | OMER |
|---|---|---|
| 09:32 ET | 1487 | 4.05 |
| 09:34 ET | 855 | 4.05 |
| 09:36 ET | 6900 | 4.035 |
| 09:38 ET | 6644 | 4.04 |
| 09:39 ET | 6100 | 4.0216 |
| 09:41 ET | 10612 | 4 |
| 09:43 ET | 2300 | 3.985 |
| 09:45 ET | 348 | 3.985 |
| 09:48 ET | 5272 | 3.94 |
| 09:52 ET | 100 | 3.93 |
| 09:54 ET | 691 | 3.98 |
| 09:57 ET | 2607 | 3.92 |
| 09:59 ET | 400 | 3.94 |
| 10:01 ET | 346 | 3.97 |
| 10:03 ET | 200 | 3.965 |
| 10:06 ET | 100 | 3.965 |
| 10:08 ET | 7425 | 4.01 |
| 10:10 ET | 2460 | 4.015 |
| 10:15 ET | 100 | 4.005 |
| 10:21 ET | 100 | 3.99 |
| 10:24 ET | 2983 | 4.01 |
| 10:30 ET | 100 | 3.99 |
| 10:33 ET | 100 | 3.99 |
| 10:35 ET | 4045 | 4 |
| 10:37 ET | 1640 | 3.96 |
| 10:39 ET | 100 | 3.96 |
| 10:42 ET | 3493 | 3.95 |
| 10:44 ET | 300 | 3.96 |
| 10:46 ET | 100 | 3.97 |
| 10:50 ET | 700 | 3.95 |
| 10:55 ET | 200 | 3.95 |
| 11:00 ET | 250 | 3.94 |
| 11:02 ET | 3231 | 3.95 |
| 11:06 ET | 100 | 3.95 |
| 11:08 ET | 787 | 3.97 |
| 11:09 ET | 433 | 3.97 |
| 11:11 ET | 500 | 3.98 |
| 11:15 ET | 200 | 3.98 |
| 11:18 ET | 200 | 3.98 |
| 11:20 ET | 1052 | 3.96 |
| 11:22 ET | 3172 | 3.935 |
| 11:24 ET | 298 | 3.9201 |
| 11:31 ET | 552 | 3.93 |
| 11:36 ET | 100 | 3.93 |
| 11:38 ET | 1300 | 3.915 |
| 11:40 ET | 200 | 3.91 |
| 11:42 ET | 200 | 3.91 |
| 11:45 ET | 100 | 3.905 |
| 11:54 ET | 1394 | 3.9012 |
| 12:02 ET | 100 | 3.91 |
| 12:03 ET | 100 | 3.91 |
| 12:16 ET | 1193 | 3.905 |
| 12:20 ET | 100 | 3.91 |
| 12:23 ET | 1065 | 3.915 |
| 12:25 ET | 300 | 3.92 |
| 12:34 ET | 2180 | 3.9489 |
| 12:36 ET | 532 | 3.95 |
| 12:45 ET | 100 | 3.96 |
| 12:48 ET | 300 | 3.96 |
| 12:52 ET | 100 | 3.965 |
| 12:57 ET | 100 | 3.96 |
| 12:59 ET | 500 | 3.97 |
| 01:03 ET | 100 | 3.96 |
| 01:08 ET | 100 | 3.96 |
| 01:14 ET | 819 | 3.97 |
| 01:15 ET | 2526 | 3.9766 |
| 01:21 ET | 100 | 3.975 |
| 01:24 ET | 413 | 3.98 |
| 01:33 ET | 300 | 3.99 |
| 01:46 ET | 600 | 3.99 |
| 01:48 ET | 100 | 3.98 |
| 01:50 ET | 200 | 3.98 |
| 01:51 ET | 343 | 3.97 |
| 01:55 ET | 100 | 3.96 |
| 01:57 ET | 2500 | 3.965 |
| 02:00 ET | 4766 | 3.95 |
| 02:02 ET | 100 | 3.95 |
| 02:06 ET | 100 | 3.95 |
| 02:08 ET | 200 | 3.95 |
| 02:09 ET | 500 | 3.94 |
| 02:11 ET | 100 | 3.94 |
| 02:13 ET | 100 | 3.94 |
| 02:15 ET | 558 | 3.95 |
| 02:18 ET | 1000 | 3.965 |
| 02:22 ET | 200 | 3.965 |
| 02:24 ET | 100 | 3.965 |
| 02:26 ET | 700 | 3.96 |
| 02:31 ET | 500 | 3.95 |
| 02:33 ET | 100 | 3.95 |
| 02:42 ET | 513 | 3.965 |
| 02:45 ET | 561 | 3.96 |
| 02:51 ET | 214 | 3.96 |
| 02:54 ET | 394 | 3.96 |
| 03:05 ET | 275 | 3.96 |
| 03:12 ET | 394 | 3.96 |
| 03:14 ET | 100 | 3.96 |
| 03:18 ET | 100 | 3.97 |
| 03:20 ET | 100 | 3.96 |
| 03:21 ET | 100 | 3.96 |
| 03:23 ET | 271 | 3.96 |
| 03:25 ET | 400 | 3.97 |
Jun 4, 2024
Omeros Announces Webcast Details for Annual Meeting of Shareholders, from 9:00AM ET on Tuesday Jun 04, 2024 by Dow Jones
9:00AM ET on Tuesday Jun 04, 2024 by Dow Jones
Jun 3, 2024
DJ Omeros Shares Rise on Balance Sheet Strengthening, from 11:33AM ET on Monday Jun 03, 2024 by Dow Jones
11:33AM ET on Monday Jun 03, 2024 by Dow JonesOmeros Corporation Further Strengthens its Balance Sheet through Series of Financing Transactions Extending Maturity on a Majority of its Outstanding Debt into 2028, from 9:00AM ET on Monday Jun 03, 2024 by Dow Jones
9:00AM ET on Monday Jun 03, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Omeros Corp | 235.3M | -1.4x | --- |
ESSA Pharma Inc | 233.3M | -8.2x | --- |
Tectonic Therapeutic Inc | 242.7M | 2.0x | --- |
Monte Rosa Therapeutics Inc | 227.5M | -1.6x | --- |
Tenaya Therapeutics Inc | 243.4M | -2.0x | --- |
Skye Bioscience Inc | 224.8M | -1.7x | --- |
Company Information
Omeros Corporation is a biopharmaceutical company. The Company is focused on discovering, developing and commercializing small-molecule and protein therapeutics for large-market and orphan indications targeting immunologic disorders, including complement-mediated diseases, cancers, and addictive and compulsive disorders. Its lead MASP-2 inhibitor, narsoplimab, targets the lectin pathway of complement and is the subject of a biologics license application pending before FDA for the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy. Its long-acting MASP-2 inhibitor, OMS1029, is in a phase I multi-ascending-dose clinical trial. OMS906, its inhibitor of MASP-3, the key activator of the alternative pathway of complement, is advancing in clinical programs for paroxysmal nocturnal hemoglobinuria and complement 3 glomerulopathy. The Company’s lead phosphodiesterase 7 inhibitor OMS527 is in clinical development for the treatment of cocaine use disorders.
Contact Information
- Headquarters
- 201 Elliott Avenue WestSEATTLE, WA, United States 98119
- Phone
- 206-676-5000
- Fax
- 206-676-5005
Executives
- Chairman of the Board, President, Chief Executive Officer
- Gregory Demopulos
- Vice President - Finance, Chief Accounting Officer, Treasurer
- Michael Jacobsen
- Vice President - Science, Chief Scientific Officer
- George Gaitanaris
- Vice President, General Counsel, Secretary
- Peter Cancelmo
- Vice President - Human Resources
- Peter Williams
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $235.3M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 57.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.46 |
EPS | $-2.90 |
Book Value | $-0.41 |
P/E Ratio | -1.4x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
